home / stock / gmda / gmda quote
Last: | $0.0327 |
---|---|
Change Percent: | -20.8% |
Open: | $0.0395 |
Close: | $0.0327 |
High: | $0.0395 |
Low: | $0.032 |
Volume: | 23,036,893 |
Last Trade Date Time: | 04/05/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.0327 | $0.0395 | $0.0327 | $0.0395 | $0.032 | 23,036,893 | 04-05-2024 |
$0.04 | $0.04 | $0.04 | $0.0435 | $0.037 | 19,715,118 | 04-04-2024 |
$0.04 | $0.0413 | $0.04 | $0.0436 | $0.0368 | 30,929,064 | 04-03-2024 |
$0.044 | $0.0376 | $0.044 | $0.0579 | $0.035 | 97,152,626 | 04-02-2024 |
$0.0373 | $0.0358 | $0.0373 | $0.0381 | $0.0303 | 51,778,241 | 04-01-2024 |
$0.0361 | $0.0466 | $0.0361 | $0.0493 | $0.0346 | 89,181,214 | 03-29-2024 |
$0.0361 | $0.0466 | $0.0361 | $0.0493 | $0.0346 | 89,181,214 | 03-28-2024 |
$0.0592 | $0.0765 | $0.0592 | $0.0765 | $0.0518 | 125,551,395 | 03-27-2024 |
$0.343 | $0.3526 | $0.343 | $0.3526 | $0.3213 | 2,183,725 | 03-26-2024 |
$0.338 | $0.3902 | $0.338 | $0.3902 | $0.3181 | 2,819,426 | 03-25-2024 |
$0.3867 | $0.4 | $0.3867 | $0.4 | $0.355 | 1,328,826 | 03-22-2024 |
$0.403 | $0.384 | $0.403 | $0.42 | $0.372 | 2,308,834 | 03-21-2024 |
$0.376 | $0.3836 | $0.376 | $0.3849 | $0.36 | 1,415,701 | 03-20-2024 |
$0.389 | $0.379 | $0.389 | $0.415 | $0.37 | 3,361,215 | 03-19-2024 |
$0.37 | $0.35 | $0.37 | $0.405 | $0.3388 | 7,637,420 | 03-18-2024 |
$0.3196 | $0.325 | $0.3196 | $0.3362 | $0.3157 | 1,122,815 | 03-15-2024 |
$0.325 | $0.35 | $0.325 | $0.3555 | $0.3225 | 1,155,661 | 03-14-2024 |
$0.3506 | $0.314 | $0.3506 | $0.355 | $0.31 | 1,537,961 | 03-13-2024 |
$0.312 | $0.34 | $0.312 | $0.34 | $0.31 | 1,789,622 | 03-12-2024 |
$0.34 | $0.34 | $0.34 | $0.3421 | $0.33 | 774,981 | 03-11-2024 |
News, Short Squeeze, Breakout and More Instantly...
Gamida Cell Ltd. Company Name:
GMDA Stock Symbol:
NASDAQ Market:
CALGARY, Alberta, April 08, 2024 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the "Company") (NASDAQ:XRTX, TSXV:XRTX, Frankfu...
CALGARY, Alberta, April 08, 2024 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANUA WKN: A3UNZ), a late-stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney d...
Shares of Ulta Beauty, Inc. (NASDAQ: ULTA) fell sharply during Wednesday’s session amid the company's presentation at the J.P. Morgan Re...